Ocampo, Shampaigne V.

HRN: 15-59-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2025
CEFUROXIME 750MG (VIAL)
07/04/2025
07/10/2025
IVT
750mg
Q8H
AGE With Moderate Dehydration
Waiting Final Action 
07/04/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2025
07/10/2025
IVT
500mg
Q8H
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: